You are increasing the chance of a serious bleed putting someone on a clopidogrel [Plavix].
There’s always a tradeoff between thrombosis and bleeding with any anticoagulant or antiplatelet drug. However, given what we now know about Iclusig’s side effects, I would expect the addition of a antiplatelet drug to provide a net benefit on the whole.
That increase in 11% in thrombosis might be a certain subpopulation if you argue the bleeding risk is neutralized.
I do not understand this sentence—please clarify.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.